Open AccessMid-term results of bioprosthetic pulmonary valve replacement in pulmonary regurgitation after tetralogy of Fallot repair
Author(s) -
Won Il Jang,
Yoon Jung Kim,
KwangHo Choi,
HongGook Lim,
Won Ho Kim,
Jin Lee
Publication year - 2012
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezs219
Subject(s) - tetralogy of fallot , medicine , pulmonary valve insufficiency , cardiology , ventricle , pulmonary valve , pulmonary insufficiency , pulmonary regurgitation , volume overload , pulmonary valve stenosis , regurgitation (circulation) , stenosis , heart failure , surgery , heart disease
Pulmonary valve replacement (PVR) is performed to reduce right ventricular (RV) volume overload, resulting in improved ventricular function and clinical status. Significant pulmonary regurgitation (PR) after tetralogy of Fallot (TOF) repair could result in RV dysfunction, exercise intolerance, arrhythmia and sudden death. The present study was conducted to investigate the mid-term clinical outcomes of PVR after TOF repair.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom